Literature DB >> 18704824

Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury.

Ahmet Guven1, Bulent Uysal, Ozgur Akgul, Hakan Cermik, Gokhan Gundogdu, Ilhami Surer, Haluk Ozturk, Ahmet Korkmaz.   

Abstract

INTRODUCTION: Nitric oxide (NO) and peroxynitrite (OONO-) are implicated in the pathophysiology of renal ischemia/reperfusion (I/R). The aim of this study was to investigate and compare the efficiency of S-methylisothiourea (SMT), an iNOS inhibitor, and mercaptoethylguanidine (MEG), a scavenger of peroxynitrite, on renal dysfunction and injury induced by I/R of rat kidney.
MATERIALS AND METHODS: Thirty-two male Sprague-Dawley rats were divided into four groups: sham-operated, I/R, I/R+SMT, and I/R+MEG. Rats were given SMT (10 mg/kg i.p.) or MEG (10 mg/kg i.p.) 6 h prior to I/R and at the beginning of reperfusion. All rats except sham-operated underwent 60 min of bilateral renal ischemia followed by 6 h of reperfusion. After reperfusion, kidneys and blood were obtained for evaluation. Superoxide dismutase, glutathione peroxidase, malondialdehide, protein carbonyl content, and nitrite/nitrate level (NO(x)) were determined in the renal tissue. Serum creatinine (S(Cr)), blood urea nitrogen (BUN), and aspartate aminotransferase (AST) were determined in the blood. Additionally, renal sections were used for histological grade of renal injury.
RESULTS: SMT and MEG significantly reduced the I/R-induced increases in S(Cr), BUN, and AST. Both SMT and MEG attenuated the tissue NO(x) levels, indicating reduced NO production. In addition, SMT and MEG markedly reduced elevated oxidative stress product, restored decreased antioxidant enzymes, and attenuated histological alterations. Interestingly, MEG exerted a greater renoprotective effect than SMT.
CONCLUSIONS: These data support the finding that iNOS and peroxynitrite are involved in the renal I/R injury, and suggest that a scavenger of peroxynitrite might be more effective than iNOS inhibitors as a therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704824     DOI: 10.1080/08860220802213039

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  7 in total

1.  Adaptive responses of rat descending vasa recta to ischemia.

Authors:  Zhong Zhang; Kristie Payne; Thomas L Pallone
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-16

2.  Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone.

Authors:  Akio Fujisawa; Yorihiro Yamamoto
Journal:  Redox Rep       Date:  2016-02-18       Impact factor: 4.412

Review 3.  Cysteamine revisited: repair of arginine to cysteine mutations.

Authors:  L Gallego-Villar; Luciana Hannibal; J Häberle; B Thöny; T Ben-Omran; G K Nasrallah; Al-N Dewik; W D Kruger; H J Blom
Journal:  J Inherit Metab Dis       Date:  2017-06-22       Impact factor: 4.982

Review 4.  The role of nitric oxide in renovascular hypertension: from the pathophysiology to the treatment.

Authors:  Bruna Pinheiro Pereira; Gabriel Tavares do Vale; Carla Speroni Ceron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-07       Impact factor: 3.000

5.  Role of superoxide-nitric oxide interactions in the accelerated age-related loss of muscle mass in mice lacking Cu,Zn superoxide dismutase.

Authors:  Giorgos K Sakellariou; Deborah Pye; Aphrodite Vasilaki; Lea Zibrik; Jesus Palomero; Tabitha Kabayo; Francis McArdle; Holly Van Remmen; Arlan Richardson; James G Tidball; Anne McArdle; Malcolm J Jackson
Journal:  Aging Cell       Date:  2011-05-06       Impact factor: 9.304

6.  Entacapone scavenges peroxynitrite and protects against kidney and liver injuries induced by renal ischemia/reperfusion in rats.

Authors:  Eman Soliman; Samar M Shewaikh; Ahmed Fahmy; Shimaa Elshazly
Journal:  Int Urol Nephrol       Date:  2021-03-06       Impact factor: 2.370

7.  Role of S-methylisothiourea (SMT) in renal ischemia/reperfusion injury in rats.

Authors:  Fatemeh Kanani; Faezeh Fazelnia; Mohaddeseh Mojarradfard; Mehdi Nematbakhsh; Fatemeh Moslemi; Fatemeh Eshraghi-Jazi; Ardeshir Talebi
Journal:  J Renal Inj Prev       Date:  2016-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.